Adinath Biolabs Profile
Key Indicators
- Authorised Capital ₹ 22.51 Cr
as on 24-10-2024
- Paid Up Capital ₹ 22.07 Cr
as on 24-10-2024
- Company Age 42 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 59.59%
(FY 2023)
- Profit 96.24%
(FY 2023)
- Ebitda -12.98%
(FY 2023)
- Net Worth -503.80%
(FY 2023)
- Total Assets -13.58%
(FY 2023)
About Adinath Biolabs
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 22.51 Cr and a paid-up capital of Rs 22.07 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Adinath Biolabs Limited India are Vivek Rana as Cfo, Yamini Guleria as Company Secretary, and Sunil Kumar as Ceo. Manoj Kumar, Sunil Kumar, Priti Vakhare, and One other member serve as directors at the Company.
- CIN/LLPIN
L24230WB1982PLC034492
- Company No.
034492
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
29 Jan 1982
- Date of AGM
13 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Adinath Biolabs?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Kumar  | Managing Director | 04-Aug-2023 | Current |
| Vivek Rana | CFO | 15-Apr-2019 | Current |
| Yamini Guleria | Company Secretary | 12-Aug-2019 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manoj Kumar | Director | 01-Oct-2020 | Current |
| Priti Vakhare | Director | 05-Feb-2021 | Current |
| Sanjoy Basu | Director | 26-Jul-2023 | Current |
Financial Performance and Corporate Structure Insights of Adinath Biolabs.
Adinath Biolabs Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 59.59% increase. The company also saw a substantial improvement in profitability, with a 96.24% increase in profit. The company's net worth observed a substantial decline by a decrease of 503.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adinath Biolabs?
In 2023, Adinath Biolabs had a promoter holding of 25.75% and a public holding of 74.24%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Light Speed Trade & Consultancy Private LimitedActive 26 years 5 months
Sunil Kumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Adinath Biolabs?
Unlock and access historical data on people associated with Adinath Biolabs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adinath Biolabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adinath Biolabs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
